arrow_back Back Filing freshness 20-F FY 2025 SEC EDGAR

111, Inc.

YI
$3.00 ▼ -0.04 (-1.32%) at close
Healthcare ·Retail-Drug Stores and Proprietary Stores ·USRetail-Drug Stores and Proprietary Stores
8 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
43
Health
Weak
Bullish
auto_awesome

Analytical Summary

111, Inc. shows strong fundamentals with top-quartile Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $522.1M
Dividend Yield —
Revenue Growth -9.0% ↘
Op. Margin -0.0% ↘
ROIC 0.3% ↗
FCF / Share $0.09 ↘
Trailing P/E —
Price / Book —
FCF Yield 3.1%
Debt / Equity -0.27
info Valuation on last close. End-of-day price, Nov 4, 2026.

8-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.80B
↓ -9.0% —
Net Income Profit after all expenses
$-3.22M
↓ -13.1% —
Operating Margin Operating profit as % of sales
-0.0%
↓ -229.3% 28th
FCF / Share Free cash flow per share
$0.09
↓ -52.3% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↑
29
Returns
50
Financial Health ↑
73
Cash Quality
3

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 8 years · 8 quarters